Creative Financial Designs’s BioMarin Pharmaceuticals BMRN Stock Holding History

Creative Financial Designs’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$282	–	2270
2026 Q1	$282	Hold	5	–	–	﹤0.01%	2064
2025 Q4	$297	Hold	5	–	–	﹤0.01%	1963
2025 Q3	$271	Buy	+5	New	+$286	﹤0.01%	1964
2021 Q4	–	Sell	-136	Closed	-$11K	–	1230
2021 Q3	$11K	Hold	136	–	–	﹤0.01%	988
2021 Q2	$11K	Hold	136	–	–	﹤0.01%	992
2021 Q1	$10K	Hold	136	–	–	﹤0.01%	928
2020 Q4	$12K	Hold	136	–	–	﹤0.01%	819
2020 Q3	$10K	Buy	136 +106	+353%	+$10.7K	﹤0.01%	796
2020 Q2	$4K	Buy	+30	New	+$2.98K	﹤0.01%	897

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Creative Financial Designs's BMRN Position: Q2 2026 in Review

Creative Financial Designs sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2026, closing a stake of 5 shares — an estimated $282 sold.

Creative Financial Designs first reported a position in BMRN in Q2 2020 and held it in 9 quarters. The position peaked at $12K in Q4 2020. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Creative Financial Designs reported no remaining BioMarin Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Creative Financial Designs sold 5 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $282.
Creative Financial Designs first reported a position in BioMarin Pharmaceuticals in Q2 2020 and held it in 9 quarters.
Creative Financial Designs's BioMarin Pharmaceuticals position peaked at $12K in Q4 2020.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.